Stock XOMAO XOMA ROYALTY CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

News XOMA Royalty Corporation Nasdaq

Equities

XOMAO

US98419J4040

Market Closed - Nasdaq
Other stock markets
 21:30:01 16/07/2024 BST 		5-day change 1st Jan Change
24.92 USD -0.91% Intraday chart for XOMA Royalty Corporation -0.48% -0.80%
07-10 XOMA Corporation will Change its Name to XOMA Royalty Corporation CI
07-09 Xoma Changes Name to Xoma Royalty MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
XOMA Corporation will Change its Name to XOMA Royalty Corporation
CI
Xoma Changes Name to Xoma Royalty
MT
XOMA Corporation(NasdaqGM:XOMA) added to Russell 3000 Growth Index
CI
XOMA Corporation(NasdaqGM:XOMA) added to Russell Microcap Growth Index
CI
XOMA Corporation(NasdaqGM:XOMA) added to Russell 3000E Growth Index
CI
XOMA Corporation(NasdaqGM:XOMA) added to Russell 2000 Growth Index
CI
XOMA Corporation(NasdaqGM:XOMA) added to Russell 2500 Growth Index
CI
XOMA Corporation(NasdaqGM:XOMA) added to Russell Small Cap Comp Growth Index
CI
XOMA Declares Quarterly Preferred Stock Dividends
AQ
XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals Sale of its Priority Review Voucher
AQ
XOMA Receives $8.1 Million Milestone Related to Sale of Priority Review Voucher
MT
XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of its Priority Review Voucher
AQ
XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ
AQ
Earnings Flash (XOMA) XOMA CORPORATION Reports Q1 Revenue $1.5M
MT
Xoma: Q1 Earnings Snapshot
AQ
Tranche Update on XOMA Royalty Corporation's Equity Buyback Plan announced on January 2, 2024.
CI
XOMA Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities
AQ
XOMA : 2024 Letter to Shareholders
PU
XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. XOMA Stock
  4. XOMAO Stock
  5. News XOMA Royalty Corporation